Mission

The Platform for Advanced Cellular Therapies – PACT was established in acknowledgement of the long and globally recognised academic excellence, the excellent teaching and training capabilities and the exceptional research infrastructure that the four Foundation Partners can confer in the provision of an exceptionally strong synergistic potential in cutting edge health-care and socioeconomic advancement for Austria and in particular Vienna and is proposed to join intellectual and structural resources. The PACT provides the forum to achieve a unified community of mutual interests and collaborations in order to create meaningful clinical research programmes and trials in the area of cellular therapies for the relief of suffering human beings and animals. The Foundation Partners involved in the PACT will contribute each to the other in order to create the synergy and the thereby added value of joint venture research endeavours into finding treatments and cures for specific conditions (also including rare diseases or “orphan” status treatments for which there are no known cures or adequate treatments). The PACT will work in close consultation with all authorities and agencies e.g. the Austrian Agency for Health and Food Safety (AGES) and the European Medicines Agency (EMA) to provide the highest appropriate standards necessary in ethics, efficacy and safety for all concerned. Within the areas of mutual interest and pending appropriate funding the Foundation Partners propose to establish forthwith and will seek to involve and harmonize research groups working on Molecular, Cellular and Regenerative Medicine as associates and/or partners in mutual research efforts within the PACT.